Madison MaynardRobert D. DvorakDaniel PaulsonEmily K. BurrQuinn AllenNichole R. LighthallApollonia E. Lysandrou2026-03-222026-03-22202510.1080/00332747.2025.2484827https://doi.org/10.1080/00332747.2025.2484827https://andeanlibrary.org/handle/123456789/77115These findings provide evidence of momentary improvements in pain, anxiety, depression, and indirect benefits for sleep quality. In combination with other findings, the results advance our understanding of the efficacy and limitations of MC among older adults. Findings are limited by MC measurement and sample homogeneity (primarily White, non-Hispanic female). Future research should seek to further measurement of use and corresponding effects and examine expectancy effects in aging clinical populations.enAnxietyCannabisSleep qualityMedical cannabisSleep (system call)PsychiatryPsychologyMedicineGerontologyClinical psychologyarticle